# Naoshi Obara

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/naoshi-obara/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,714 |
| Field | Acute Myeloid Leukemia Research |
| h-index | 27 |
| i10-index | 53 |
| Last Known Institution | University of Tsukuba Hospital |
| OpenAlex ID | https://openalex.org/A5068565363 |
| ORCID iD | 0000-0001-6563-3093 |
| Works | 166 |

## Researcher papers

- [Frequent pathway mutations of splicing machinery in myelodysplasia](https://scholariq.org/papers/frequent-pathway-mutations-of-splicing-machinery-in-myelodysplasia/)
- [Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms](https://scholariq.org/papers/recurrent-mutations-in-multiple-components-of-the-cohesin-complex-in-myeloid/)
- [Repression via the GATA box is essential for tissue-specific erythropoietin gene expression](https://scholariq.org/papers/repression-via-the-gata-box-is-essential-for-tissue-specific-erythropoietin-gene/)
- [Nuclear Receptors TR2 and TR4 Recruit Multiple Epigenetic Transcriptional Corepressors That Associate Specifically with the Embryonic β-Type Globin Promoters in Differentiated Adult Erythroid Cells](https://scholariq.org/papers/nuclear-receptors-tr2-and-tr4-recruit-multiple-epigenetic-transcriptional/)
- [Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels](https://scholariq.org/papers/identification-and-characterization-of-2-types-of-erythroid-progenitors-that/)
- [Interleukin-6 and Tumor Necrosis Factor-α in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome](https://scholariq.org/papers/interleukin-6-and-tumor-necrosis-factor-in-patients-with-obstructive-sleep-apnea/)
- [Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice](https://scholariq.org/papers/reduced-tet2-function-leads-to-t-cell-lymphoma-with-follicular-helper-t-cell/)
- [Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial](https://scholariq.org/papers/addition-of-danicopan-to-ravulizumab-or-eculizumab-in-patients-with-paroxysmal/)
- [Clinical significance of disease‐specific <i><scp>MYD</scp>88</i> mutations in circulating <scp>DNA</scp> in primary central nervous system lymphoma](https://scholariq.org/papers/clinical-significance-of-disease-specific-i-scp-myd-scp-88-i-mutations-in/)
- [Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease](https://scholariq.org/papers/oral-administration-of-k-11706-inhibits-gata-binding-activity-enhances-hypoxia/)
- [Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria](https://scholariq.org/papers/hemolysis-induced-by-sars-cov-2-mrna-vaccination-in-patients-with-paroxysmal/)

## Researcher topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Blood groups and transfusion](https://scholariq.org/topics/blood-groups-and-transfusion/)

## Researcher university

- [University of Tsukuba Hospital](https://scholariq.org/institutions/university-of-tsukuba-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.